Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.8K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.8K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

1.6K
The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.6K
Humoral Immune Responses01:36

Humoral Immune Responses

78.2K
Overview
78.2K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

25
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
25
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.3K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aberrant STAT signaling and T cell dysregulation define a targetable pediatric sepsis endotype.

The Journal of clinical investigation·2026
Same author

Cefepime pharmacokinetics in critically ill children with multiple organ dysfunction syndrome using volumetric absorptive microsampling.

Antimicrobial agents and chemotherapy·2026
Same author

Anti-PD-L1 therapy to prevent systemic immune suppression after polytraumatic brain injury in rats.

The journal of trauma and acute care surgery·2026
Same author

A study within a trial evaluating supplemental, reinforced risk-based training to reduce implementation barriers in a pediatric multicenter randomized controlled trial.

Contemporary clinical trials·2026
Same author

Drug Administration Patterns in Patients on Extracorporeal Membrane Oxygenation.

Journal of pediatric intensive care·2026
Same author

Real-World Tocilizumab Use in Pediatric Inpatients.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG·2025
Same journal

Five-Year Risk of CIN3+ After CIN1 Biopsy in a Norwegian Screening Setting: Comparison of CIN1 Diagnosed in a Single Calendar Year and in Two Consecutive Calendar Years.

Pathogens (Basel, Switzerland)·2026
Same journal

Ventilator-Associated Pneumonia (VAP) Prevention Bundle: A Multicenter Cross-Sectional Saudi Study to Assess Knowledge, Adherence, and Perceived Barriers Among ICU Practitioners in Hail Region.

Pathogens (Basel, Switzerland)·2026
Same journal

Anti-<i>Borrelia</i> IgG Seropositivity Among Hemodialysis Patients with Chronic Kidney Disease of Unknown Etiology: A Preliminary Case-Control Study from Northern Türkiye.

Pathogens (Basel, Switzerland)·2026
Same journal

Molecular Characterization of Hemotropic <i>Mycoplasma</i> spp. From Bats (Chiroptera) in the Northern Pantanal, Brazil.

Pathogens (Basel, Switzerland)·2026
Same journal

Characterization of Durum-Einkorn Amphiploids for Introgression of Powdery Mildew Resistance from Einkorn into Common Wheat.

Pathogens (Basel, Switzerland)·2026
Same journal

Human Orthohantavirus Infections: A Narrative Review.

Pathogens (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Oct 15, 2025

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

6.5K

Immune Function in Critically Ill Septic Children.

Katherine Elizabeth Bline1, Mark W Hall1

  • 1Division of Critical Care Medicine, Department of Pediatrics, Nationwide Children's Hospital, Columbus, OH 43205, USA.

Pathogens (Basel, Switzerland)
|October 23, 2021
PubMed
Summary
This summary is machine-generated.

Pediatric sepsis involves complex immune responses. Severe cases can lead to "immunoparalysis," a dangerous acquired immunodeficiency increasing risks for infection, organ dysfunction, and death in children.

Keywords:
TNFαimmuneinflammationmodulationpediatricresponsesepsissuppression

More Related Videos

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.3K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.2K

Related Experiment Videos

Last Updated: Oct 15, 2025

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

6.5K
A Controlled Mouse Model for Neonatal Polymicrobial Sepsis
14:54

A Controlled Mouse Model for Neonatal Polymicrobial Sepsis

Published on: January 27, 2019

11.3K
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
07:30

Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression

Published on: June 15, 2019

10.2K

Area of Science:

  • Pediatric critical care medicine
  • Immunology
  • Infectious diseases

Background:

  • Pediatric sepsis presents a dynamic inflammatory response involving both pro-inflammatory and anti-inflammatory immune system components.
  • A compensatory anti-inflammatory response can lead to acquired immunodeficiency, termed 'immunoparalysis' when severe.
  • Immunoparalysis in pediatric sepsis is linked to heightened risks of nosocomial infections, prolonged organ dysfunction, and mortality.

Purpose of the Study:

  • To review the pathophysiology of immune dysregulation in pediatric sepsis.
  • To discuss the clinical implications of over- and under-active immune responses.
  • To examine risk factors and potential immunomodulatory strategies for pediatric sepsis-induced immunoparalysis.

Main Methods:

  • Literature review focusing on the immune response in pediatric sepsis.
  • Analysis of host, disease, and treatment factors contributing to immunoparalysis.
  • Examination of current clinical trials for immunomodulatory approaches.

Main Results:

  • The inflammatory response in pediatric sepsis is biphasic, with pro-inflammatory and anti-inflammatory phases.
  • Immunoparalysis represents a significant clinical challenge, increasing morbidity and mortality.
  • Various factors influence the development of immunoparalysis, necessitating tailored treatment strategies.

Conclusions:

  • Understanding the dual nature of immune responses in pediatric sepsis is crucial for effective management.
  • Identifying and mitigating risk factors for immunoparalysis can improve patient outcomes.
  • Immune phenotype-specific immunomodulation holds promise for treating pediatric sepsis and preventing its severe consequences.